Lin L H, Van Eldik L J, Osheroff N, Norden J J
Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Brain Res Mol Brain Res. 1994 Sep;25(3-4):297-304. doi: 10.1016/0169-328x(94)90165-1.
The effect of the glial-derived protein, S100 beta, on the in vitro phosphorylation of the growth-associated protein GAP-43 was investigated. S100 beta inhibited in a dose dependent manner the phosphorylation of GAP-43 by protein kinase C (PKC) or by casein kinase II (CKII). S100 beta appeared to slow down the rate and the degree to which GAP-43 can be phosphorylated by either kinase. The specificity of the inhibition was demonstrated by the observation that the phosphorylation of two other CKII substrates, casein and a selective peptide substrate, was not inhibited by S100 beta. The marked inhibitory effect of S100 beta required the presence of calcium in the phosphorylation reactions. In addition, S100 beta inhibition of GAP-43 phosphorylation was seen with GAP-43 purified under a variety of conditions that alter acylation, suggesting that the acylation state of GAP-43 does not affect the ability of S100 beta to modulate CKII- or PKC-mediated phosphorylation of GAP-43.
研究了神经胶质源性蛋白S100β对生长相关蛋白GAP-43体外磷酸化的影响。S100β以剂量依赖性方式抑制蛋白激酶C(PKC)或酪蛋白激酶II(CKII)对GAP-43的磷酸化。S100β似乎减缓了GAP-43被任一激酶磷酸化的速率和程度。通过观察另外两种CKII底物(酪蛋白和一种选择性肽底物)的磷酸化未被S100β抑制,证明了抑制的特异性。S100β的显著抑制作用需要磷酸化反应中存在钙。此外,在多种改变酰化状态的条件下纯化的GAP-43均可见S100β对GAP-43磷酸化的抑制,这表明GAP-43的酰化状态不影响S100β调节CKII或PKC介导的GAP-43磷酸化的能力。